Active-ingredient Dossier
Azacitidine
Active-ingredient Dossier for Azacitidine (cytidine analogue antimetabolite). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: Azacitidine
- Brand: ONUREG
- Brand: VIDAZA
- Brand: AZACITIDINE
- Brand: AZACITIDINE
- Brand: AZACITIDINE
- Therapeutic area: Oncology
What is
Azacitidine Azacitidine is a cytidine analogue antimetabolite.
Australian brands containing
Azacitidine — Azacitidine — ONUREG — VIDAZA — AZACITIDINE-TEVA — APO-Azacitidine — AZACCORD — AZACIDE
Therapeutic areas
Azacitidine is registered in oncology, with 17 brands containing this ingredient on the ARTG.
Sponsor landscape
Azacitidine is marketed by nine sponsors: Cipla, Dr Reddys Laboratories, Arrotex Pharmaceuticals, Accord Healthcare, Eugia Pharma, and Bristol-Myers Squibb.
PBS and regulatory activity
Two brands containing azacitidine have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 September 2022, and the latest AusPAR was published on 11 April 2013.